675
Views
9
CrossRef citations to date
0
Altmetric
Case Reports

Long-term response to peginterferon in hepatitis C virus-associated nephrotic syndrome from focal segmental glomerulosclerosis

&
Pages 1182-1185 | Received 25 Mar 2013, Accepted 03 Jun 2013, Published online: 23 Jul 2013

References

  • Kim WR. The burden of hepatitis C in the United States. Hepatology. 2002;36:S30–S34
  • Sterling RK, Bralow S. Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep. 2006;8:53–59
  • Fabrizi F, Dixit V, Martin P, Messa P. The evidence-based epidemiology of HCV-associated kidney disease. Int J Artif Organs. 2012;35:621–628
  • Stehman-Breen C, Alpers CE, Couser W, et al. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol. 1995;43:141–147
  • Sumida K, Ubara Y, Hoshino J, Suwabe T, Nakanishi S, Hiramatsu R, et al. Hepatitis C virus-related kidney disease: various histological patterns. Clin Nephrol. 2010;74:446–456
  • Markowitz GS, Cheng JT, Colvin RB, Trebbin WM. Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol. 1998;9:2244–2252
  • Altraif IH, Abdulla AS, al Sebayel MI, Said RA, al Suhaibani MO, Jones AA. Hepatitis C associated glomerulonephritis. Am J Nephrol. 1995;15:407–410
  • Choo Q-L, Kuo G, Wener AJ, et al. Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359–362
  • Noureddine LA, Usman SA, Yu Z, Moorthi RN, Moe SM. Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis. Am J Nephrol. 2010;32:311–316
  • Fabrizi F, Martin P, Dixit V, Messa P. Hepatitis C virus infection and kidney disease: a meta-analysis. Clin J Am Soc Nephrol. 2012;7:549–557
  • Fabrizi F, Pozzi C, Farina M, Dattolo P, Lunghi G, Badalamenti S, et al. Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal. Nephrol Dial Transplant. 1998;13:1991–1997
  • Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C infection. N Engl J Med. 1993;328:465–470
  • McGuire BM, Julian BA, Bynon JS Jr, et al. Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med. 2006;144:735–741
  • Ezaki Y, Tanaka U, Minoshima S, et al. FSGS associated with hepatitis C and decrement of proteinuria by interferon. Nippon Jinzo Gakkai. 1999;41:83–88
  • Bruchfeld A, Lindahl K, Stahle L, et al. Interferon and ribavirin treatment in patients with hepatitis C associated renal disease and renal insufficiency. Nephrol Dial Transplant. 2003;18:1573–1580
  • Yamabe H, Johnson RJ, Gretch Dr, et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol. 1995;6:220–223
  • Abou-Zeid AA, El-Sayegh HK. Toll-like receptor 3 gene expression in Egyptian patients with glomerulonephritis and hepatitis C virus infection. Scand J Clin Lab Invest. 2011;71:456–461
  • Sansonno D, Lauletta G, Montrone M, et al. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture micro dissection. Clin Expt Immunology. 2005;140:498–506
  • Motta M, Malaguarnera M, Restuccia N, Romano M, Vinci E, Pistone G. Focal segmental glomerulosclerosis and hepatitis C virus: a case report. Panminerva Med. 2001;43:49–52
  • Mihm U, Herrmann E, Sarrazin C, Zeuzem S. Review article: predicting response in hepatitis C virus therapy. Aliment Pharmacol Ther. 2006;23:1043–1054
  • Morales JM, Kamar N, Rostaing L. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy. Contrib Nephrol. 2012;176:10–23
  • Sperati J. Stabilization of Hepatitis C associated collapsing focal segmental glomerulosclerosis with interferon a-2a and ribavirin. Clin Nephrol 2012. doi 10.5414/CN107337

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.